祖拉诺在患有抑郁症的患者中的有效性和耐受性:随机对照试验的元分析

相关实验视频

Updated: Jul 4, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Youjia Qiu¹, Yuchen Tao², Aojie Duan¹

¹Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

Frontiers in pharmacology

|January 30, 2024

概括

与安慰剂相比,祖拉诺显示出快速的短期抗抑郁作用,显著改善了抑郁症的严重程度,增加了反应和缓解率. 虽然头和昏昏欲睡等治疗出现的不良事件更频繁,但它们通常是轻微的和暂时的.

科学领域:

药理学药理学是指药理学的学科.
神经科学是一个神经科学.
精神病学是一个精神病学.

背景情况:

祖拉诺是一种新型抗抑郁药物.
这项研究评估了祖拉诺在治疗抑郁症中的有效性和安全性.

研究的目的:

评估祖拉诺在减轻抑郁症严重性的有效性.
为了确定祖拉诺对抑郁症缓解和反应率的影响.
评估祖拉诺的安全性,包括治疗出现的不良事件.

主要方法:

一个系统的审查和对祖拉诺治疗抑郁症的研究的元分析.
在Embase,PubMed和Cochrane图书馆的数据库中搜索到2023年11月1日.
包括1884名患者的6项研究,分析抑郁症严重程度得分,缓解/反应率和不良事件.
进行试验顺序分析 (TSA) 来评估样本大小的充分性.

主要成果:

与安慰剂相比,祖拉诺在第15天显著改善了抑郁症严重性得分 (MD = 2.43,p < 0.00001).
使用祖拉诺观察到更高的响应率 (RR = 1.33,p < 0.0001) 和缓解率 (RR = 1.46,p = 0.002).
治疗出现的不良事件 (TEAE) 的发生率增加,特别是头和昏昏欲睡,在祖拉诺 (RR = 1.15,p = 0.0005) 中被注意到.

结论:

祖拉诺具有快速的短期抗抑郁药疗效.
与祖拉诺相关的不良事件大多是轻微的和短暂的.
需要进一步研究,采用更大的样本大小和更长的随访时间来证实研究结果.

关键词:

抑郁抑郁症抑郁症抑郁症抑郁症大型抑郁症主要是抑郁症.进行元分析和元分析.产后抑郁症产后抑郁症这种药物是zuranolone.

更多相关视频

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Anxiolytic Drugs: Overview

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...